Ahmed Elzoghby, PhD
Combined Exosome Release Inhibitory & Fibroblast Phenotype Reversal Nanomedicines Normalize CAFs & Potentiate Cancer Immunotherapy
Combined Exosome Release Inhibitory & Fibroblast Phenotype Reversal Nanomedicines Normalize CAFs & Potentiate Cancer Immunotherapy
PAX8-directed nanotherapeutics for high-grade serous ovarian cancer